Global In-Silico Drug Discovery Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global In-Silico Drug Discovery market size will reach 3,009.19 Million USD in 2025 and is projected to reach 5,995.92 Million USD by 2032, with a CAGR of 10.35% (2025-2032). Notably, the China In-Silico Drug Discovery market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
In-silico drug discovery, also known as computer-aided drug design, is a computational approach used to identify and optimize potential drug candidates before they are synthesized and tested in the laboratory. This methodology involves the use of computer algorithms, molecular modeling techniques, and bioinformatics tools to simulate and analyze the interactions between drug molecules and biological targets such as proteins, enzymes, or receptors. By leveraging large databases of chemical compounds, protein structures, and biological data, in-silico drug discovery enables researchers to predict the binding affinity, pharmacokinetic properties, and potential efficacy of candidate compounds in silico, thereby accelerating the drug discovery process and reducing the time and cost associated with traditional experimental approaches. In-silico methods play a crucial role in prioritizing promising drug candidates, optimizing lead compounds, and rationalizing drug design decisions, ultimately leading to the development of safer, more effective, and targeted therapeutics for various diseases.
The major global suppliers of In-Silico Drug Discovery include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schrödinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG), etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of In-Silico Drug Discovery. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global In-Silico Drug Discovery market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the In-Silico Drug Discovery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Silico Drug Discovery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of In-Silico Drug Discovery Include:
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
In-Silico Drug Discovery Product Segment Include:
Software as a Service
Consultancy as a Service
In-Silico Drug Discovery Product Application Include:
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global In-Silico Drug Discovery Industry PESTEL Analysis
Chapter 3: Global In-Silico Drug Discovery Industry Porter's Five Forces Analysis
Chapter 4: Global In-Silico Drug Discovery Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global In-Silico Drug Discovery Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global In-Silico Drug Discovery Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, In-Silico Drug Discovery Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global In-Silico Drug Discovery market size will reach 3,009.19 Million USD in 2025 and is projected to reach 5,995.92 Million USD by 2032, with a CAGR of 10.35% (2025-2032). Notably, the China In-Silico Drug Discovery market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
In-silico drug discovery, also known as computer-aided drug design, is a computational approach used to identify and optimize potential drug candidates before they are synthesized and tested in the laboratory. This methodology involves the use of computer algorithms, molecular modeling techniques, and bioinformatics tools to simulate and analyze the interactions between drug molecules and biological targets such as proteins, enzymes, or receptors. By leveraging large databases of chemical compounds, protein structures, and biological data, in-silico drug discovery enables researchers to predict the binding affinity, pharmacokinetic properties, and potential efficacy of candidate compounds in silico, thereby accelerating the drug discovery process and reducing the time and cost associated with traditional experimental approaches. In-silico methods play a crucial role in prioritizing promising drug candidates, optimizing lead compounds, and rationalizing drug design decisions, ultimately leading to the development of safer, more effective, and targeted therapeutics for various diseases.
The major global suppliers of In-Silico Drug Discovery include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schrödinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG), etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of In-Silico Drug Discovery. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global In-Silico Drug Discovery market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the In-Silico Drug Discovery market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Silico Drug Discovery industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of In-Silico Drug Discovery Include:
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
In-Silico Drug Discovery Product Segment Include:
Software as a Service
Consultancy as a Service
In-Silico Drug Discovery Product Application Include:
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global In-Silico Drug Discovery Industry PESTEL Analysis
Chapter 3: Global In-Silico Drug Discovery Industry Porter's Five Forces Analysis
Chapter 4: Global In-Silico Drug Discovery Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global In-Silico Drug Discovery Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global In-Silico Drug Discovery Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, In-Silico Drug Discovery Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 In-Silico Drug Discovery Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 In-Silico Drug Discovery Product by Type
- 1.2.1 Software as a Service
- 1.2.2 Consultancy as a Service
- 1.3 In-Silico Drug Discovery Product by Application
- 1.3.1 Contract Research Organization
- 1.3.2 Pharmaceutical Industry
- 1.3.3 Academic and Research Institutes
- 1.3.4 Others
- 1.4 Global In-Silico Drug Discovery Market Size Analysis (2020-2032)
- 1.5 In-Silico Drug Discovery Market Development Status and Trends
- 1.5.1 In-Silico Drug Discovery Industry Development Status Analysis
- 1.5.2 In-Silico Drug Discovery Industry Development Trends Analysis
- 2 In-Silico Drug Discovery Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 In-Silico Drug Discovery Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global In-Silico Drug Discovery Market Analysis by Country
- 4.1 Global In-Silico Drug Discovery Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global In-Silico Drug Discovery Revenue Analysis by Country (2020-2025)
- 4.1.2 Global In-Silico Drug Discovery Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.5 China In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.6 France In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.14 India In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa In-Silico Drug Discovery Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global In-Silico Drug Discovery Market Revenue by Key Suppliers (2021-2025)
- 5.2 In-Silico Drug Discovery Competitive Landscape Analysis and Market Dynamic
- 5.2.1 In-Silico Drug Discovery Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 In-Silico Drug Discovery Market Analysis by Type
- 6.1 Global In-Silico Drug Discovery Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global In-Silico Drug Discovery Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Charles River
- 7.1.1 Charles River Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Charles River In-Silico Drug Discovery Product Portfolio
- 7.1.3 Charles River In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Certara USA, Inc.
- 7.2.1 Certara USA, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Certara USA, Inc. In-Silico Drug Discovery Product Portfolio
- 7.2.3 Certara USA, Inc. In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Evotec
- 7.3.1 Evotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Evotec In-Silico Drug Discovery Product Portfolio
- 7.3.3 Evotec In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Dassault System (Biovia)
- 7.4.1 Dassault System (Biovia) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Dassault System (Biovia) In-Silico Drug Discovery Product Portfolio
- 7.4.3 Dassault System (Biovia) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Albany Molecular Research Inc. (AMRI)
- 7.5.1 Albany Molecular Research Inc. (AMRI) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product Portfolio
- 7.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Selvita
- 7.6.1 Selvita Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Selvita In-Silico Drug Discovery Product Portfolio
- 7.6.3 Selvita In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Schrödinger, Inc.
- 7.7.1 Schrödinger, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Schrödinger, Inc. In-Silico Drug Discovery Product Portfolio
- 7.7.3 Schrödinger, Inc. In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 GVK BIO
- 7.8.1 GVK BIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 GVK BIO In-Silico Drug Discovery Product Portfolio
- 7.8.3 GVK BIO In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 OpenEye Scientific Software
- 7.9.1 OpenEye Scientific Software Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 OpenEye Scientific Software In-Silico Drug Discovery Product Portfolio
- 7.9.3 OpenEye Scientific Software In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Chemical Computing Group (CCG)
- 7.10.1 Chemical Computing Group (CCG) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Chemical Computing Group (CCG) In-Silico Drug Discovery Product Portfolio
- 7.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 In-Silico Drug Discovery Industry Chain Analysis
- 8.2 In-Silico Drug Discovery Product Downstream Application Analysis
- 8.2.1 Global In-Silico Drug Discovery Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global In-Silico Drug Discovery Revenue and Forecast by Application (2020-2032)
- 8.3 In-Silico Drug Discovery Typical Downstream Customers
- 8.4 In-Silico Drug Discovery Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
